MTOR and laryngotracheoesophageal cleft: Mechanistically, we found that B cells from D-LC patients had reduced OXPHOS and glycolysis after activation, which may result from reduced glucose uptake, mitochondrial dysfunction (reduced MMP and increased mitochondrial ROS), and attenuated activation of the AKT/mTOR pathway.